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Both heredity and environment can affect the
hepatic microsomal drug-metabolizing enzyme
systems and the response of these enzymes to
stimulators, inducers, and inhibitors. A large
number of references could be cited in which the
levels or the response of these enzymes were
studied in various purebred strains of a single
animal species, or in one animal species vs.
another, as well as how various stresses or strains
applied to animals or man affected these systems
and how various pollutants, pesticides, etc., ap-
plied by different routes to animals or man,
caused changes in the drug-metabolizing en-
zymes. It is not my purpose to review the general
area of environmental factors influencing drug
metabolism, but rather to pick out some selected
problems on which my laboratory has worked
or which I feel need some comments at this
time.
Papers at international symposia often divide
into two classes: general summaries of the status
of a given research area or the author’s work in
that area, on the latest, often as yet unpublished,
and “hottest” on most controversial findings of a
laboratory. A third approach can also be use-
ful-some analyses of pitfalls or roadblocks in
the research efforts, or a discussion of commonly
overlooked or ignored parameters that confound
the interpretation of data in that field. It is per-
haps for this last purpose that I have been asked
to contribute to this symposium. In my opinion,
environment, in all its contributions, probably
causes as much confusion in the interpretation of
variations in hepatic microsomal dnug-metaboliz-
ing enzyme activity as any other influence. The
fact that large areas of our environment have
not yet been tested for their effects on hepatic
microsomal enzymes also contributes to our
“hunch” that this source of biological variation
is large and important and will continue to plague
us for a long time.
This is not the place or the time to engage in
prolonged polemics about the relative importance
ofheredity vs. environment in hepatic microsomal
drug-metabolizing enzyme activity. I would,
however, caution against the assumption that
any evidence we now have will allow us to
draw general conclusions in this argument.
Statements have appeared that the major factor
controlling drug metabolism is heredity. In my
opinion there is no current data that allows
such a sweeping statement to be made. Instead,
I think the few facts we have suggest that both
heredity and environment can play determining
roles depending on experimental circumstances
which in turn can be quite normal. I think the
interactions of heredity and environment need
a lot more attention than they presently receive,
and we are particularly concerned about this
interaction in some of the studies in my labora-
tory, as I will describe below.
The body of this paper will present some re-
cent work in my laboratory dealing with stimula-
tion (induction) of benzpynene hydnoxylase and
other mixed function oxidases in liver of rats vs.
mice by DDT, benzpynene, and 3-methylcholan-
threne, and some studies we have completed on
metal ion effects on microsomal electron trans-
port.
As a part of this discussion I will comment
briefly on some problems we have found in some
of our studies and those of others dealing with
effects of environment on xenobiotic on drug
metabolisms.
Stimulation of Benzpyrene Metabolism by
3-Methylcholanthrene and Benzpyrene
Almost everyone who has tried to measure the
rate of metabolism of benzpynene by microsomes
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of various tissues has had to deal with difficul-
ties such as the following. 1) The reaction velocity
is linear with time and protein concentration
only oven relatively small ranges. 2) The en-
zyme assay standard used (a hydroxybenzpyrene
metabolite) is available in very limited quantities
and somewhat variable purity, as well as being
only one of the reaction products produced.
3) The substrate (benzpynene) is of variable
purity and great insolubility in water. 4) Most
vehicles used to add this substrate to the enzyme
systems are themselves effectors of that system.
5) Increases in enzyme activity (after animal
treatment with enzyme “inducers’ ‘) are often ac-
companied by apparent changes in enzyme
kinetics and therefore possible changes in condi-
tions needed for optimal activity (e.g., pH, sub-
strate concentration, cofactor concentration, pro-
tein concentration, incubation time, etc.). 6) The
substrate (and metabolites?) associate readily
with proteins and the availability of these hydro-
carbons to sites of metabolism is very much a
function of protein concentration in the incuba-
tion mixture. Both very high and very low pro-
tein concentration in the incubation mixture can
cause problems. Too little protein usually means
the added substrate precipitates out and is not
available to the enzyme; some carrier protein
like albumin must be added when small amounts
of microsomes are used in the benzpynene hy-
droxylase assay. Too much protein often means
benzpynene is totally bound by inert protein
and its availability to the hydnoxylase enzyme
may be the nate-limiting step in the reaction.
This seems to occur at low substrate concentra-
tions on when one uses tissue homogenates as
enzyme source or when microsomal protein
concentrations (in the incubation mixture) exceed
I mg/mI.
In a recent paper we have discussed some of
our laboratory’s problems with benzpynene me-
tabolism by liven microsomes from control and
“induced” rats vs. mice (I). A number of our
findings seemed noteworthy to us.
1 . Although theory dictates that accurate esti-
mates of K M should be obtained by using sub-
strate concentrations in the immediate range of
K M  this is very difficult to do with benzpyrene
hydnoxylase in microsomes from induced rats.
The K M for the polycyclic hydrocarbon-induced
enzyme is in the neighborhood of 10-40 MM.
Substrate concentrations in this range do not
yield usable data with reasonable microsomal
protein concentrations (up to I mg/ml), and
even very short incubation times (less than 3
mm).
2. The most important aspect in enzyme as-
says to determine benzpynene hydroxylase ac-
tivity in liver microsomes from induced rats is
the ratio of microsomal protein to substrate
(benzpyrene) concentration. The absolute level of
protein on substrate concentration is relatively
unimportant if the ratios are kept so that there
is high substrate relative to protein concentration.
Thus, in an incubation mixture containing I mg
of microsomal protein per ml, the substrate con-
centration may need to be about 400 uM even if
incubation time is kept to less than 5 mm.
3. Albumin may be needed as a carrier of
benzpyrene when the only protein present is that
contributed by microsomes. However, good ki-
netic data can be generated by systems contain-
ing dispersed benzpyrene, where the disperser
is not albumin but rather something like Tween
80.
4. Time-course curves of benzpynene hydnoxyl-
ation by liver microsomes from induced rats can
show a disappearance of metabolite(s) with time,
especially when lower substrate concentrations
( <40 MM) or long incubation times ( > 3 mm)
are used. This is not obvious when liven micro-.
somes from untreated rats or mice are used,
even at low substrate concentrations (10-40 MM)
and longer incubation times (up to 10 mm). In
these experiments, the same microsomal pro-
tein concentration (I mg/ml) was used with in-
cubations of microsomes from control vs. in-
duced animals. At low substrate concentrations
( <40 MM) and relatively short incubation times
(5 mm), measured benzpynene metabolism by
induced preparations can be noticeably /ess than
by control preparations-an apparent contradic-
tion.
5. Fluorescence spectra of benzpyrene me-
tabolite(s) produced by liver microsomes from
control vs. induced rats are different, especially
during the earliest phases of the incubation
( <3 mm) of microsomes with relatively low
concentrations of substrate ( < 40 MM). After
longer times of incubation ( > 5 mm) the fluones-
cence spectra become similar when comparing
control and induced microsomal metabolites.
There seems to be a disappearance of some of the
early metabolites as detected spectrally when
one uses microsomes from induced rats.
The disappearance of benzpynene metabolites
seen at lower substrate concentrations in incuba-
tions with microsomes from induced rats is not
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seen at higher substrate concentrations with in-
duced microsomes or even at low substrate con-
centrations with control microsomes. This may
be due to inhibition of further metabolism of
these metabolite(s) by the substrate. Parent com-
pounds can often inhibit further metabolism of
their metabolites (2). Relatively more parent
compound (benzpyrene) could be available for
such inhibition in microsomes from control vs.
induced animals even at the same substrate and
microsomal protein concentrations, since the
relative concentration of active binding sites can
be much higher in induced vs. control prepara-
tions. This follows if we can assume that the
active binding site (for metabolite metabolism
and therefore the site of inhibitor action) is cyto-
chrome P-450, since cytochrome P-450 concen-
tration pen milligram of microsomal protein is
usually higher in induced vs. control rat liven
microsomes.
The benzpyrene hydroxylase system is espe-
cially interesting to environmental health sci-
ence research, since it I) is present in most ani-
mal species and in a number of extrahepatic tis-
sues; 2) is affected by a variety of widely used
chemicals and drugs; 3) can be assayed by very
sensitive methods requiring very small amounts
of tissues; and 4) seems to play a role in a num-
ber of important results, such as whether certain
chemicals are necrogenic, carcinogenic, etc.
Other advantages are its ability to be rapidly
induced in tissue culture, its ability to be de-
tected and localized histochemically, and its rela-
tive stability upon storage.
Disadvantages of this system seem to be over-
looked on occasion and need to be stated and
recognized more often, in my opinion. The
benzpyrene hydnoxylase system does not respond
well to the class of general dnug-metabolizing
enzyme inducers. This class includes the vast
majority of clinically useful drugs such as the
barbiturates, minor tranquilizers, and antihista-
mines, as well as the most widely used pesti-
cides such as DDT, chlondane, and dieldnin, or
widespread pollutants such as the polychlorinated
biphenyls. Non does the enzyme system depend
on the normal form of cytochnome P-450, but
rather seems to have a specific requirement for
cytochrome P-448 (on P ,-450) which is either a
distinct and different cytochnome or at least a
new form of cytochnome P-450 (3). In addition,
at least in some tissues, the enzyme seems to be
present only if the tissue is exposed to inducers
(4). These drawbacks should be added to those
of the enzyme activity assay itself, especially
the problems of analysis when microsomes from
induced animals are used as I have just dis-
cussed (I).
Thus, although the assay of benzpyrene hydrox-
ylase as a marker for enzyme induction and as
an enzyme of great importance to environmental
health and cancer research will continue to in-
crease, I hope its use as a marker of hepatic
microsomal drug metabolism or as a typical
drug-metabolizing enzyme system will be tem-
pered by a realization of its peculiar nature. Re-
suits obtained with this enzyme system alone
as an indicator of effect should not be extrap-
olated to suggest analogous effects on toxica-
tion-detoxication systems in general.
Species Differences in Response to DDT
and Benzpyrene
Species differences in response to inducers of
hepatic microsomal drug-metabolizing enzymes
may account for species differences in duration
on toxicity of chemicals as determined acutely,
or especially as studied chronically. Induction of
dnug-metabolizing enzymes may be the basis of
several kinds of unexpected drug-drug, drug-
chemical, and chem ical-environmental intenac-
tions to produce changes in action and toxicity of
drugs and chemicals. My laboratory has been
especially interested in species and strain differ-
ences in drug-metabolizing enzyme inducibility
by phenobanbital, DDT, and benzpyrene. In one
of our first studies we showed that six strains of
rabbits differed in their response to hepatic
microsomal enzyme induction by phenobanbital
(5). This response variation included not only
whether and how much a given rabbit strain ne-
sponded to enzyme induction by phenobarbital,
but whether a given drug’s metabolism was af-
fected in all on only a few rabbit strains. Among
the six strains of rabbits, the California and
English strains seemed less responsive to pheno-
barbital than others, and jacknabbits seemed
most responsive (defined as total number of
drug metabolisms stimulated as a fraction of
total number of enzyme activities studied). Of
the drug metabolisms studied, only one was
induced in all six strains (hexobarbital oxidase)
while two were not increased in any strain (am-
phetamine deamination and chlorpnomazine
sulfoxidation).
Our current work, some of which was ne-
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ported at the recently concluded Fifth Interna-
tional Congress on Pharmacology (6) is con-
cerned with the reasons for the relative unre-
sponsiveness of mice to DDT and benzpyrene as
enzyme inducers as compared with rats. We
found several years ago that doses of DDT on
benzpyrene which produced easily measured
increases in hepatic microsomal drug metabo-
lisms in rats produced only marginal or no ap-
parent stimulation of analogous enzymes in
preparations from treated vs. control mice
(7-10).
Our most recent findings indicate that part of
the differences between mice and rats may be
found in the dose-response and time-response
relationships of enzyme induction. Thus, in the
mouse, much larger doses of DDT and benzpy-
nene were needed (relative to doses used in rats)
to produce measurable stimulation of most
hepatic microsomal enzyme systems, and the
stimulation lasted for much shorter times in
mice than in rats. The stimulations achievable
by the largest doses of DDT and benzpyrene
used were also much less than those seen in rats.
The largest doses of DDT and benzpynene that
we gave to the mice were very close to the LD50
of these compounds in these mice (as deter-
mined in our laboratory). Such huge doses create
confounded experiments which must at least be
admitted. Thus, very high doses of any chemical
may produce hepatic microsomal enzyme induc-
tion by virtue of its action as a nonspecific stress.
This can occur almost regardless of its route of
administration or other variables (vehicle,
volume administered, etc.). Thus, enzyme in-
duction occurring only at high doses of an in-
ducen, having relatively short duration, having
a relatively flat dose-response curve and low
ceiling (stimulation being of the order of 2-fold
rather than 5- to 10-fold), and not resulting in
features distinguishing it from stress-induced
induction, is a kind of induction that should be
looked at very carefully.
At present, in our mice, we have no clean-cut
answers to the question whether the enzyme
stimulation seen is due to the benzpyrene and
DDT or to the stress they create in the treated
mice. All the evidence points to differences of
great quantitative and at least slight qualitative
nature between enzyme induction in rats vs. mice
by DDT and benzpyrene. One especially interest-
ing finding is that benzpyrene administration to
mice at doses producing increased hepatic micro-
somal benzpyrene hydroxylase and aniline hy-
droxylase activity does not produce a shift of
the cytochnome P-450-CO difference spectra
from 450 to 448 nm. Also, the shift in pH optima
for aniline hydroxylase that is produced when
rats respond to benzpynene as inducer is not
seen in the mouse (1 1 - 13, and unpublished data).
All of these considerations strengthen our suspi-
cions that our original conclusions were correct
(7, 8); i.e., DDT and benzpyrene are not stimu-
latons of hepatic microsomal enzymes in the
mice that we use (Swiss-Webster). The drug-
metabolizing enzyme responses we can see at high
doses of DDT on benzpyrene are possibly due to
a generalized stress phenomena which could be
created by large amounts of almost any chemi-
cal that is truly inactive as an inducer of drug-
metabolizing enzymes, but is administered near
its LD60. We are studying this problem further,
but the general principle is one I wish to empha-
size strongly: enzyme induction by a chemical
should be distinguished from enzyme induction
due to stress created by that chemical, if at all
possible.
Metal Ion Effects on NADPH-Cytochrome
P-450 Reductase Activity
The rate-limiting step in mixed function oxi-
dase-cytochrome P-450-dependent microsomal
drug metabolisms seems to be located in the
area of electron transfer between NADPH and
the cytochrome P-450-substrate complex. This
step is measured in several ways by people who
all talk of the activity of “cytochnome P-450
reductase.” The most widely used assay system
is probably that described by Gigon et al. (14)
or a modification of this. The system seems to
measure the rate at which NADPH reduces
cytochnome P-450 in the presence of CO and
this “cytochrome P.450 reductase” activity
is described as though it were a zero-order ne-
action, at least under the proper conditions.
Given the right “mix” of equipment, enzyme
preparation, etc., it is possible to generate a
A (at 450 nm) vs. time plot that looks linear
and from which one can therefore calculate a
cytochnome P-450 reductase activity. This linear
portion of the curve is usually relatively short
in duratmon and depends on a number of factors,
which can include how anaerobic the assay sys-
tem is. Traces of oxygen have been blamed by
several groups for any deviation from linearity
which initial rates of cytochnome P.450 ne-
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ductase can often show. Ways of removing the
last traces of oxygen from the cytochnome P-450
neductase assay system may not be acceptable
for all studies one may wish to make on this
system. These oxygen removals may require
extended bubbling of microsomal suspensions
with CO on oxygen-free nitrogen-a procedure
that can denature protein or at least alter
pnotein-dnug-chemical interactions. One might
also remove dissolved oxygen by adding a system
that uses it up, such as certain oxidizing enzymes
and their substrates. This works well as long as
the added enzyme and substrate and cofactors
and buffers and metals are not themselves ef-
fectons of the NADPH-cytochnome P-450 reduc-
tase-drug complex you wish to study. So far, we
are somewhat disillusioned by the fact that the
most rapidly responding spectnophotometric sys-
tem we can use-the stop-flow, rapid mixing
Aminco-Mornow attachment in the Aminco-
Chance spectrophotometer operated in the dual
beam (single wavelength) mode-gives us curves
of #{163}4vs. time even during the first 100 msec
of the reaction. One can distinguish differences
in rates of generation of these curves by tempera-
tune, pH, substrates, and ions, and therefore
demonstrate stimulation and inhibition of the
cytochnome P-450-reductase system; however,
in our opinion, the results may best be described
by the raw data and not by a transformation of
these curves into line tangents and calculation of
rates from them, even though we and others are
doing this in several of our publications.
My main point in this section concerns our
studies on metal ion effects on cytochnome P-450
neductase. Several years ago we studied effects
of magnesium on hepatic microsomal drug me-
tabolisms (15, 16) and showed that the stimula-
tory effects of magnesium on drug metabolism
could be correlated with stimulation by magne-
sium of microsomal NADPH-cytochnome c ne-
ductase on NADPH-cytochnome P-450 re-
ductase. Some of our recent work has studied
the effects of several metal ions and of ionic
strength on cytochnome P-450 reductase in the
presence and absence of substrates and with liver
microsomes from control vs. induced rats.
Some of our findings that we think interesting
and of possible importance to environmental
pollutant effects were as follows.
1. Most divalent cations stimulated cyto-
chrome P.450 neductase unless these cations
were sulfhydryl-reactive. At higher concentra-
tions ( > I -5 mM), such sulfhydnyl-neactive
metals were inhibitory to cytochrome P-450
reductase. Most monovalent cations were much
less effective than divalent ions or ineffective in
stimulation or inhibition of cytochnome P-450
reductase. The few trivalent cations studied were
inactive or inhibitory. Inhibition of cytochnome
P-450 reductase was often associated with effects
on microsomal suspension: the microsomes
seemed to settle out faster.
2. Stimulation of cytochnome P-450 reductase
by type I substrates (benzphetamine) could add
to stimulation by magnesium. Inhibition of cyto-
chrome P-450 reductase by type II substrates
could be partially reversed by magnesium.
3. Microsomes from 3-methylcholanthrene-
treated rats were less responsive to stimulation by
both type I substrates (benzphetamine) and mag-
nesium than microsomes from control rats.
4. Cytochnome P-450 reductase was stimu-
lated by phenobarbital pretreatment of rats, but
little on not at all by 3-methylcholanthrene treat-
ment of rats.
5. Cytochnome P-450 reductase could be stim-
ulated by increased ionic strength (using KCI). At
very high ionic strengths (100-300 mM KC1),
magnesium stimulation of cytochnome P-450 re-
ductase was progressively blocked out until only
the lessen (even when maximal) stimulation by
KC1 was seen. Thus microsomes in 0. 1 M KCI or
in metal ion-chelating buffers (such as phosphate)
will not show cytochrome P-450 reductase stimu-
lation by magnesium and other divalent ions. Even
higher concentrations of nonionic buffers like
Hepes (N-2-hydroxyethylpipenazine-N’-2-ethane-
sulfonic acid) can block out magnesium effects in
a dose-related fashion. The effects of magnesium
on rat liver cytochrome P-450 reductase were
seen best by us using Hepes buffer at 0. 1 M or
less.
6. The effects of magnesium on cytochnome
P-450 reductase were not just those due to ionic
strength, since the stimulation by magnesium was
greater than that seen at the maximal effect of
added KCI or buffer. Also, the effects of magne-
sium could be seen at ionic strengths much less
than the thresholds for KCI effects.
7. Many of our findings with cytochrome P-450
reductase seem to apply to NADPH-cytochnome
c neductase: metal ions and increased ionic
strength produce stimulations of that enzyme
also (16-18).
Thus ionic strength, buffer, added metal ions
as well as added substrates and whether micro-
somes come from control or inducer-treated rats
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Discussion of this paper was deferred until after the paper of Hodgson et a!.
can all affect measured cytochnome P-450 reduc-
tase activity. Comparisons of cytochnome P-450
neductase in microsomes must therefore carefully
control for these variables if such comparisons are
to be interpretable. Extrapolation of results ob-
tamed in vitro back to the in vivo situation may
be difficult, since little is known of the metal ion-
substrate environment in the in vivo situation.
This remains a largely overlooked problem, in my
opinion, and complicates a lot of the decisions
about how and when cytochrome P-450 reductase
becomes the rate-limiting step for microsomal
drug metabolisms.
Some Conduding Remarks
I have talked about a few of my specific re-
search projects that seem to involve both micro-
somal drug metabolisms and the environment. In
the presentation of this data I have tried to point
out some problems that have made these expeni-
ments hard to do or less than easy to interpret. I
have not discussed a wide variety of envinonmen-
tal factors that plague all of us in our studies of
these enzymes and their role in regulating or con-
tnibuting to a given drug action on toxicity. Nor
have I any more than alluded to the interactions
of heredity and environment that may confound
all our attempts to extrapolate animal expeni-
ments to man. The interesting work of Gielen,
Goujon, and Nebert should be at least recalled:
certain strains of mice seem to have lost or at
least be deficient in the ability to respond to en-
vinonmental inducers of drug metabolisms (19).
Perhaps some men also lack responsiveness to
environmental on other inducens. Perhaps some
environmental effects in animals require genes
found in no humans.
In this paper, I have presented a few examples
in some detail to illustrate some principles. I have
tried to present some of our newer studies on
those which do not seem to be as widely known as
others. In ending this report, I hope the reader
will not forget that this symposium has focused
on a very small part of the total processes in ani-
mals for drug and chemical disposition. The he-
patic, microsomal, cytochnome P-450-depend-
ent mixed function oxidases are anything but
typical of the animal on human system(s) for
handling exogenous and endogenous chemicals.
Most of the substrates we use for these few and
very selected mixed function oxidase systems are
also untypical of the vast array of chemicals to
which we are exposed or which we use in therapy
of disease. The ability to extrapolate our results
from in vitro to in vivo is relatively untested, and
our knowledge about these enzyme systems has
been derived largely from studies in only one
species-rats. The fact that these considerations
often do not temper our enthusiasm for the data
we gather, nor seem to restrict our use of these
data to make predictions, should be recognized
by all of us as a possible source of trouble now
and in the future.
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